Back
Structure Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
23
GPCR
Structure Therapeutics
Last Price:
$18.75
Seasonality Move:
15.51%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.05 | Sell |
| 20-day SMA: | 21.35 | Sell |
| 50-day SMA: | 23.23 | Sell |
| 200-day SMA: | 28.09 | Sell |
| 8-day EMA: | 20.86 | Sell |
| 20-day EMA: | 21.44 | Sell |
| 50-day EMA: | 22.13 | Sell |
| 200-day EMA: | 26.9 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 38.49 | Sell |
| Chaikin Money Flow: | 34208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 22.16) | Sell |
| Bollinger Bands (100): | (19.07 - 24.79) | Sell |
Structure Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 20.37 while GPCR 8-day simple moving average is 21.05, which is a Sell signal.
-
The stock price of GPCR is 20.37 while Structure Therapeutics 20-day SMA is 21.35, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 23.23 while GPCR share price is 20.37, making it a Sell technically.
-
GPCR stock price is 20.37 and Structure Therapeutics 200-day simple moving average is 28.09, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
23
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $20.37. The Score for GPCR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
20.37
Share Volume:
372.5K
Structure Therapeutics 52-Week Range
52-Week High:
47.48
52-Week Low:
13.22
Sell
23
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 20.37 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 20.37 while GPCR 8-day exponential moving average is 20.86, which is a Sell signal.
-
The stock price of GPCR is 20.37 while Structure Therapeutics 20-day EMA is 21.44, which makes it a Sell.
-
Structure Therapeutics 50-day exponential moving average is 22.13 while GPCR share price is 20.37, making it a Sell technically.
-
GPCR stock price is 20.37 and Structure Therapeutics 200-day simple moving average is 26.90, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Structure Therapeutics is a Sell
-
Structure Therapeutics Relative Strength Index (RSI) is 38.49, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (20.8 - 22.16), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (19.07 - 24.79), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.